Paper32229068
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.
Katzenellenbogen JA. Nucl Med Biol, 2021. Cited by 54 papers, by iCite.
Cite this record
ConductScience Library. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review. Papers, record 32229068. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32229068
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Estradiol | Major topic |
| Positron-Emission Tomography | Major topic |
| Receptors, Estrogen | Major topic |
| Animals | |
| Female | |
| Humans | |
| History, 20th Century | |
| History, 21st Century | |
| Radioactive Tracers |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA025836 | NCI NIH HHS | United States | R01CA025836 | PubMed and NIH | NIH RePORTER |
| R37 CA025836 | NCI NIH HHS | United States | R01CA025836 | PubMed and NIH | NIH RePORTER |
| R37CA025836 | NIH | NIH RePORTER |
References144
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7830275 | Fluorine-18-labeled progestin 16 alpha, 17 alpha-dioxolanes: development of high-affinity ligands for the progesterone receptor with high in vivo target site selectivity. | J Med Chem | 1995 | https://conductscience.org/library/papers/7830275 | PubMed |
| 2 | 12884843 | SNM highlights as history: 1983. | J Nucl Med | 2003 | https://conductscience.org/library/papers/12884843 | PubMed |
| 3 | 25476421 | Rapid synthesis of [18F]fluoroestradiol: remarkable advantage of microwaving over conventional heating. | J Labelled Comp Radiopharm | 2014 | https://conductscience.org/library/papers/25476421 | PubMed |
| 4 | 10334533 | Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10334533 | PubMed |
| 5 | 11882788 | Theory and practice of imaging saturable binding sites. | Invest Radiol | 2002 | https://conductscience.org/library/papers/11882788 | PubMed |
| 6 | 25520392 | Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy. | Clin Cancer Res | 2015 | https://conductscience.org/library/papers/25520392 | PubMed |
| 7 | 164893 | Iodohexestrols. II. Characterization of the binding and estrogenic activity of iodinated hexestrol derivatives, in vitro and in vivo. | Biochemistry | 1975 | https://conductscience.org/library/papers/164893 | PubMed |
| 8 | 31732674 | Recent Advances in Imaging Steroid Hormone Receptors in Breast Cancer. | J Nucl Med | 2020 | https://conductscience.org/library/papers/31732674 | PubMed |
| 9 | 8003436 | Synthesis of (17 alpha,20E/Z)iodovinyl testosterone and 19-nortestosterone derivatives as potential radioligands for androgen and progesterone receptors. | J Steroid Biochem Mol Biol | 1994 | https://conductscience.org/library/papers/8003436 | PubMed |
| 10 | 6292423 | Nonsteroidal estrogens: synthesis and estrogen receptor binding affinity of derivatives of (3R*,4S*)-3,4-bis(4-hydroxyphenyl)hexane (hexestrol) and (2R*,3S*)-2,3-bis(4-hydroxyphenyl)pentane (norhexestrol) functionalized on the side chain. | J Med Chem | 1982 | https://conductscience.org/library/papers/6292423 | PubMed |
| 11 | 8401374 | Titration of the in vivo uptake of 16 alpha-[18F]fluoroestradiol by target tissues in the rat: competition by tamoxifen, and implications for quantitating estrogen receptors in vivo and the use of animal models in receptor-binding radiopharmaceutical development. | Nucl Med Biol | 1993 | https://conductscience.org/library/papers/8401374 | PubMed |
| 12 | 7562040 | Positron tomographic assessment of estrogen receptors in breast cancer: comparison with FDG-PET and in vitro receptor assays. | J Nucl Med | 1995 | https://conductscience.org/library/papers/7562040 | PubMed |
| 13 | 8355567 | 16 beta-[18F]fluoromoxestrol: a potent, metabolically stable positron emission tomography imaging agent for estrogen receptor positive human breast tumors. | Life Sci | 1993 | https://conductscience.org/library/papers/8355567 | PubMed |
| 14 | 16459252 | Molecular targets. | Nucl Med Biol | 2006 | https://conductscience.org/library/papers/16459252 | PubMed |
| 15 | 1125197 | Iodohexestrols. I. Synthesis and photoreactivity of iodinated hexestrol derivatives. | Biochemistry | 1975 | https://conductscience.org/library/papers/1125197 | PubMed |
| 16 | 10481160 | The Molecular Pharmacology of SERMs. | Trends Endocrinol Metab | 1999 | https://conductscience.org/library/papers/10481160 | PubMed |
| 17 | 21982568 | Factors influencing the uptake of 18F-fluoroestradiol in patients with estrogen receptor positive breast cancer. | Nucl Med Biol | 2011 | https://conductscience.org/library/papers/21982568 | PubMed |
| 18 | 9794874 | Ovarian ablation in breast cancer, 1896 to 1998: milestones along hierarchy of evidence from case report to Cochrane review. | BMJ | 1998 | https://conductscience.org/library/papers/9794874 | PubMed |
| 19 | 27491481 | Phase II trial of neoadjuvant letrozole and lapatinib in Asian postmenopausal women with estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2)-positive breast cancer [Neo-ALL-IN]: Highlighting the TILs, ER expressional change after neoadjuvant treatment, and FES-PET as potential significant biomarkers. | Cancer Chemother Pharmacol | 2016 | https://conductscience.org/library/papers/27491481 | PubMed |
| 20 | 1701833 | 11 beta-methoxy-, 11 beta-ethyl- and 17 alpha-ethynyl-substituted 16 alpha-fluoroestradiols: receptor-based imaging agents with enhanced uptake efficiency and selectivity. | J Med Chem | 1990 | https://conductscience.org/library/papers/1701833 | PubMed |
Cited by32
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42776062 | The Next Frontier in Quantitative Co-Clinical Imaging to Advance Functional Precision Oncology. | Clin Cancer Res | 2026 | https://conductscience.org/library/papers/42776062 | PubMed |
| 42722783 | Macrocycle Chelator Conjugation on the C3 Hydroxyl Group of 17β-Estradiol reduces Estrogen Receptor Binding. | Mol Imaging Biol | 2026 | https://conductscience.org/library/papers/42722783 | PubMed |
| 42492092 | [18F]FDG PET/MRI for axillary staging in node positive breast cancer patients receiving primary systemic therapy. A prospective single arm trial. | Breast | 2026 | https://conductscience.org/library/papers/42492092 | PubMed |
| 42078117 | Rationale and Trial Design of DAWNA-FES Trial: Single-Arm Phase II Study of Endocrine Therapy With Dalpiciclib After Progression on CDK4/6 Inhibition Based on [18F]FES PET/CT in Patients With HR+/HER2- Advanced Breast Cancer. | Cancer Innov | 2026 | https://conductscience.org/library/papers/42078117 | PubMed |
| 41940065 | A comprehensive review of de novo oligometastatic breast cancer: Current treatment options, surgical outcomes, and systemic therapy. | North Clin Istanb | 2026 | https://conductscience.org/library/papers/41940065 | PubMed |
| 40968016 | Hybrid [18F] Fluoroestradiol Brain PET/CT/MRI for Detection of Estrogen Receptor-Positive Intracranial Metastases Compared with MRI and Vertex-to-Below the Knees PET Imaging. | AJNR Am J Neuroradiol | 2025 | https://conductscience.org/library/papers/40968016 | PubMed |
| 40820148 | A novel solid phase synthesis of an estradiol derivative and preclinical evaluation for targeting estrogen-receptor positive breast cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/40820148 | PubMed |
| 40773017 | Quantitative and simplified [18F] fluoroestradiol positron emission tomography (PET) measures of brain estrogen receptor expression. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/40773017 | PubMed |
| 40427142 | The Role of [18F]FES PET/CT in Breast Cancer Management: An Umbrella Review. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40427142 | PubMed |
| 39333775 | EDB-FN-targeted probes for near infrared fluorescent imaging and positron emission tomography imaging of breast cancer in mice. | Sci Rep | 2024 | https://conductscience.org/library/papers/39333775 | PubMed |
| 39272726 | Radiotracer Innovations in Breast Cancer Imaging: A Review of Recent Progress. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39272726 | PubMed |
| 39170834 | Characterization of an Estrogen Receptor α-Selective 18 F-Estradiol PET Tracer. | World J Nucl Med | 2024 | https://conductscience.org/library/papers/39170834 | PubMed |
| 39136565 | Estrogen Receptor-targeted PET Imaging for Breast Cancer. | Radiology | 2024 | https://conductscience.org/library/papers/39136565 | PubMed |
| 39123367 | Radiosynthesis and Preclinical Evaluation of 18F-Labeled Estradiol Derivatives with Different Lipophilicity for PET Imaging of Breast Cancer. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39123367 | PubMed |
| 39058489 | ER-Targeted PET for Initial Staging and Suspected Recurrence in ER-Positive Breast Cancer. | JAMA Netw Open | 2024 | https://conductscience.org/library/papers/39058489 | PubMed |
| 38993095 | A Single-Arm Phase II Clinical Trial of Fulvestrant Combined with Neoadjuvant Chemotherapy of ER+/HER2- Locally Advanced Breast Cancer: Integrated Analysis of 18F-FES PET-CT and Metabolites with Treatment Response. | Cancer Res Treat | 2025 | https://conductscience.org/library/papers/38993095 | PubMed |
| 38902275 | In vivo brain estrogen receptor density by neuroendocrine aging and relationships with cognition and symptomatology. | Sci Rep | 2024 | https://conductscience.org/library/papers/38902275 | PubMed |
| 38753748 | Molecular Imaging of Steroid Receptors in Breast Cancer. | Cancer J | 2024 | https://conductscience.org/library/papers/38753748 | PubMed |
| 38338854 | Imaging Molecular Targets and Metabolic Pathways in Breast Cancer for Improved Clinical Management: Current Practice and Future Perspectives. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38338854 | PubMed |
| 37494470 | Expression of the excitatory opsin ChRERα can be traced longitudinally in rat and nonhuman primate brains with PET imaging. | Sci Transl Med | 2023 | https://conductscience.org/library/papers/37494470 | PubMed |
Genes10
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AFP | 174 | PubTator's text mining | https://conductscience.org/library/genes/174 | NCBI Gene |
| ALB | 213 | PubTator's text mining | https://conductscience.org/library/genes/213 | NCBI Gene |
| AR | 367 | PubTator's text mining | https://conductscience.org/library/genes/367 | NCBI Gene |
| ATP6AP1 | 537 | PubTator's text mining | https://conductscience.org/library/genes/537 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| EREG | 2069 | PubTator's text mining | https://conductscience.org/library/genes/2069 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
| PIK3CA | 5290 | PubTator's text mining | https://conductscience.org/library/genes/5290 | NCBI Gene |
| SHBG | 6462 | PubTator's text mining | https://conductscience.org/library/genes/6462 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32229068
GET https://conductscience.org/api/papers/v1/32229068/references?page=2